TNFSF15 and inflammatory bowel disease: Notably inhibition of TL1A function by either anti-TL1A neutralizing antibody or deletion of death receptor 3 reduces numbers of intestinal fibroblasts and myofibroblasts in murine DSS colitis, the model of human IBD (107).